All articles tagged with #kidney cancer
Brad Arnold, the Mississippi-born lead singer who wrote 3 Doors Down’s breakout hit Kryptonite and steered the band to multi-platinum success, died in his sleep at 47 after a battle with stage-four kidney cancer. The news follows his 2025 diagnosis and notes his past struggles with alcohol addiction, including rehab in 2016.
Brad Arnold, the frontman of 3 Doors Down, died at 47 after a battle with stage 4 kidney cancer. Tributes poured in from fellow rock musicians who toured with him in the 2000s, including Brent Smith of Shinedown, Alter Bridge, Sevendust, Creed and Mark Tremonti, praising his kindness and influence. Arnold co-founded 3 Doors Down and rose to fame with Kryptonite from The Better Life, and he had spoken publicly about his illness in recent years.
Brad Arnold, 47, the frontman of 3 Doors Down, has died after a battle with stage 4 kidney cancer. The band confirmed the news on social media, prompting tributes from fellow rock musicians who recalled his kindness, mentorship, and role in launching the band’s breakout era with Kryptonite from The Better Life. Arnold co-founded 3 Doors Down in Escatawpa, Mississippi, and in recent years spoke openly about his cancer while thanking fans for their support.
Brad Arnold, lead singer of Mississippi rock band 3 Doors Down, died at 47 after a battle with stage 4 kidney cancer, passing away in his sleep. He wrote Kryptonite in high school and helped bring mainstream rock to a broad audience; the band earned two Grammy nominations and released six albums, most recently Us and the Night in 2016. Arnold had revealed his cancer last year and the tour was canceled as a result.
Brad Arnold, the lead singer, founding member and original drummer of rock band 3 Doors Down, has died at 47 in his sleep after battling stage 4 kidney cancer. Arnold revealed his diagnosis in May and canceled the band’s tour; he’s remembered as a key figure in early-2000s rock, penning hits like Kryptonite (written in his math class at age 15) and helping redefine mainstream rock. He is survived by his wife, Jennifer, and family.
Brad Arnold, lead singer of 3 Doors Down best known for Kryptonite, died at 47 after a battle with stage 4 clear cell renal cell carcinoma that had metastasized to his lungs; he passed away in his sleep with his wife by his side.
Brad Arnold, founder and frontman of 3 Doors Down, died at 47 on February 7, 2026 after battling clear cell renal cell carcinoma (ccRCC); the band announced he passed away peacefully in his sleep with his wife Jennifer by his side, after canceling tours in 2025 due to the illness, and he is remembered for writing hits like 'Kryptonite' and for his faith, sobriety, and charitable work.
A Oklahoma mother spent years being told her persistent pain was “just gas” before an Oct 2024 MRI revealed Stage 1 kidney cancer. After removing the tumor in 2025, she investigated a possible environmental cause and found her home’s ice machine was moldy, producing Ochratoxin A, a mycotoxin linked to kidney damage. Doctors say a direct cause can’t be proven, but mold exposure can trigger inflammation and organ injury. Removing the ice machine led to symptom relief, and she is now cancer-free, underscoring the potential health risks of household toxins and the importance of considering home environments in unexplained illnesses.
Two small Nature Medicine trials suggest oral fecal microbiota transplantation (FMT) pills may boost immunotherapy in advanced cancers: in metastatic kidney cancer, FMT reduced immunotherapy side effects and produced about a 50% response; in advanced lung cancer or melanoma, combining FMT with immunotherapy yielded response rates around 75–80%, higher than typical 39–45% rates. While promising, results are early and require larger trials.
Two Nature Medicine studies show that fecal microbiota transplantation (FMT) capsules can both reduce immunotherapy-related toxicity in kidney cancer and improve response rates in lung cancer and melanoma—80% of lung cancer patients and 75% of melanoma patients responded to immunotherapy after FMT (significantly higher than immunotherapy alone) in multicenter Phase II trials using LND101 capsules.
To reduce the risk of kidney cancer, maintain a healthy lifestyle by quitting smoking, staying active, controlling blood sugar and blood pressure, staying well hydrated, avoiding toxic chemicals, and monitoring symptoms and kidney health through regular checkups.
A study by Texas A&M University suggests that arsenic in tap water, consumed by up to 40 million Americans, may increase the risk of kidney cancer. The research found that even low arsenic levels, considered safe by the FDA, were linked to a higher cancer risk. Arsenic, a toxic mineral found in groundwater, can damage DNA and increase cancer risk. The study highlights the vulnerability of those using private wells, particularly in states like Nevada, Washington, and California, where arsenic levels are higher. Kidney cancer rates in the U.S. have been rising, with arsenic exposure being a potential contributing factor.
New research from the NIH suggests that faint white lines on fingernails could indicate a rare genetic condition, BAP1 tumor predisposition syndrome, which increases the risk of various cancers, including kidney, skin, and eye cancers. The study found that 88% of people with this genetic disorder had abnormal nail markings, such as a thin white line running the length of the nail, often associated with benign tumors. This condition affects fewer than 100 American families and is linked to more aggressive and early-onset cancers.
Dr. W. Kimryn Rathmell, a renowned kidney cancer expert and influential leader in cancer research and patient care, has begun her role as the 17th director of the National Cancer Institute (NCI). Selected by President Biden, Dr. Rathmell brings decades of experience in advancing research and driving innovation to improve care for cancer patients. She is known for her work in understanding the molecular and genetic drivers of kidney cancer and has contributed to the discovery of new biomarkers for early detection and treatment. Dr. Rathmell is committed to mentoring the next generation of physician-scientists and will lead NCI in pursuing the goals of President Biden's Cancer Moonshot initiative.
Actor Dolph Lundgren revealed that he was diagnosed with kidney cancer in 2015 and was told by a doctor that he only had two to three years to live. Lundgren underwent surgery and therapy, but a tumor was found in his liver. He sought a second opinion and received treatment that targeted a mutation common in lung cancer, which shrunk his tumors by about 90 percent. Lundgren is sharing his story to raise awareness and help others in similar situations.